---
title: "ENWEI PHARMACEUTICAL released its first-quarter performance, with a net profit attributable to the parent company of 16.31 million yuan, a year-on-year increase of 93.56%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/236677705.md"
description: "According to the Zhitong Finance APP, ENWEI PHARMACEUTICAL disclosed its first-quarter report for 2025, showing that the company achieved revenue of 196 million yuan during the reporting period, a year-on-year increase of 7.10%; net profit attributable to the parent company was 16.31 million yuan, a year-on-year increase of 93.56%; and net profit excluding non-recurring gains and losses was 14.62 million yuan, a year-on-year increase of 118.93%. The basic earnings per share were 0.1635 yuan"
datetime: "2025-04-20T09:05:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/236677705.md)
  - [en](https://longbridge.com/en/news/236677705.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/236677705.md)
---

# ENWEI PHARMACEUTICAL released its first-quarter performance, with a net profit attributable to the parent company of 16.31 million yuan, a year-on-year increase of 93.56%

According to the Zhitong Finance APP, ENWEI PHARMACEUTICAL (301331.SZ) disclosed its first-quarter report for 2025. During the reporting period, the company achieved revenue of 196 million yuan, a year-on-year increase of 7.10%; net profit attributable to the parent company was 16.31 million yuan, a year-on-year increase of 93.56%; and net profit excluding non-recurring gains and losses was 14.62 million yuan, a year-on-year increase of 118.93%. The basic earnings per share were 0.1635 yuan

### Related Stocks

- [301331.CN](https://longbridge.com/en/quote/301331.CN.md)

## Related News & Research

- [ANALYSIS-China's shifting energy mix weakens pillar of global LNG growth](https://longbridge.com/en/news/294314731.md)
- [BUZZ-Sleep apnea pill developer Apnimed poised to jump in debut after upsized IPO](https://longbridge.com/en/news/294533308.md)
- [Ensurge Micropower secures NOK 20 million in convertible loan commitments at NOK 1 per share](https://longbridge.com/en/news/294529118.md)
- [IRB: Q1FY27 net profit jumped 51% YoY, supported by toll growth and InvIT gains](https://longbridge.com/en/news/294325669.md)
- [Atlantic Sapphire restructuring buyer Coral HoldCo launches mandatory tender offer at NOK 0.8 a share](https://longbridge.com/en/news/294393073.md)